Cargando…

Streptococcal Immunity Is Constrained by Lack of Immunological Memory following a Single Episode of Pyoderma

The immunobiology underlying the slow acquisition of skin immunity to group A streptococci (GAS), is not understood, but attributed to specific virulence factors impeding innate immunity and significant antigenic diversity of the type-specific M-protein, hindering acquired immunity. We used a number...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pandey, Manisha, Ozberk, Victoria, Calcutt, Ainslie, Langshaw, Emma, Powell, Jessica, Rivera-Hernandez, Tania, Ho, Mei-Fong, Philips, Zachary, Batzloff, Michael R., Good, Michael F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5222516/ https://www.ncbi.nlm.nih.gov/pubmed/28027314 http://dx.doi.org/10.1371/journal.ppat.1006122

Ejemplares similares

Skin infection boosts memory B-cells specific for a cryptic vaccine epitope of group A streptococcus and broadens the immune response to enhance vaccine efficacy
por: Pandey, Manisha, et al.
Publicado: (2018)

Physicochemical characterisation, immunogenicity and protective efficacy of a lead streptococcal vaccine: progress towards Phase I trial
por: Pandey, Manisha, et al.
Publicado: (2017)

Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines
por: Reynolds, Simone, et al.
Publicado: (2021)

Streptolysin O Deficiency in Streptococcus pyogenes M1T1 covR/S Mutant Strain Attenuates Virulence in In Vitro and In Vivo Infection Models
por: Langshaw, Emma L., et al.
Publicado: (2023)

Antibodies to the conserved region of the M protein and a streptococcal superantigen cooperatively resolve toxic shock-like syndrome in HLA-humanized mice
por: Pandey, Manisha, et al.
Publicado: (2019)

Novel platform technology for modular mucosal vaccine that protects against streptococcus
por: Zaman, Mehfuz, et al.
Publicado: (2016)

Contribution of cryptic epitopes in designing a group A streptococcal vaccine
por: Ozberk, Victoria, et al.
Publicado: (2018)

A Glycolipidated-liposomal peptide vaccine confers long-term mucosal protection against Streptococcus pyogenes via IL-17, macrophages and neutrophils
por: Ozberk, Victoria, et al.
Publicado: (2023)

Polymeric epitope-based vaccine induces protective immunity against group A Streptococcus
por: Chen, Shuxiong, et al.
Publicado: (2023)

Prime-Pull Immunization with a Bivalent M-Protein and Spy-CEP Peptide Vaccine Adjuvanted with CAF®01 Liposomes Induces Both Mucosal and Peripheral Protection from covR/S Mutant Streptococcus pyogenes
por: Ozberk, Victoria, et al.
Publicado: (2021)

Antibodies to group A streptococcal virulence factors, SIC and DRS, increase predilection to GAS pyoderma
por: Karmarkar, Mohan G, et al.
Publicado: (2015)

Mechanism of Protection Induced by Group A Streptococcus Vaccine Candidate J8-DT: Contribution of B and T-Cells Towards Protection
por: Pandey, Manisha, et al.
Publicado: (2009)

Prospective Surveillance of Invasive Group A Streptococcal Disease, Fiji, 2005–2007
por: Steer, Andrew C., et al.
Publicado: (2009)

Differing Efficacies of Lead Group A Streptococcal Vaccine Candidates and Full-Length M Protein in Cutaneous and Invasive Disease Models
por: Rivera-Hernandez, Tania, et al.
Publicado: (2016)

Combinatorial liposomal peptide vaccine induces IgA and confers protection against influenza virus and bacterial super‐infection
por: Zaman, Mehfuz, et al.
Publicado: (2021)

Immunological Evaluation of Lipopeptide Group A Streptococcus (GAS) Vaccine: Structure-Activity Relationship
por: Zaman, Mehfuz, et al.
Publicado: (2012)

Pneumococcal Phasevarions Control Multiple Virulence Traits, Including Vaccine Candidate Expression
por: Phillips, Zachary N., et al.
Publicado: (2022)

Antibodies to neutralising epitopes synergistically block the interaction of the receptor‐binding domain of SARS‐CoV‐2 to ACE 2
por: Pandey, Manisha, et al.
Publicado: (2021)

IMMUNOLOGIC RELATION OF STREPTOCOCCAL AND TISSUE ANTIGENS : III. PRESENCE IN HUMAN SERA OF STREPTOCOCCAL ANTIBODY CROSS-REACTIVE WITH HEART TISSUE. ASSOCIATION WITH STREPTOCOCCAL INFECTION, RHEUMATIC FEVER, AND GLOMERULONEPHRITIS
por: Kaplan, Melvin H., et al.
Publicado: (1964)

Poly(amino acids) as a potent self-adjuvanting delivery system for peptide-based nanovaccines
por: Skwarczynski, Mariusz, et al.
Publicado: (2020)

IMMUNOLOGIC INCOMPETENCE OF IMMUNOLOGICALLY RUNTED ANIMALS
por: Blaese, R. Michael, et al.
Publicado: (1964)

Facial Pyoderma Gangrenosum in Senescence
por: Kratzsch, Dorothea, et al.
Publicado: (2013)

M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP)
por: Mills, Jamie-Lee S., et al.
Publicado: (2020)

Author Correction: M-protein based vaccine induces immunogenicity and protection from Streptococcus pyogenes when delivered on a high-density microarray patch (HD-MAP)
por: Mills, Jamie-Lee S., et al.
Publicado: (2020)

Pyoderma gangrenosum associated with alitretinoin therapy
por: Levy, Jonathan Michael Stephen, et al.
Publicado: (2016)

Pyoderma Gangranosum of the Penis
por: Kim, Tae Heung, et al.
Publicado: (2009)

Penile pyoderma gangrenosum
por: Philip, Mariam, et al.
Publicado: (2013)

Pyoderma gangrenosum: An update
por: Bhat, Ramesh M.
Publicado: (2012)

Genital pyoderma gangrenosum
por: Bhat, Ramesh M., et al.
Publicado: (2014)

The quest for GAS vaccine
por: Pandey, Manisha, et al.
Publicado: (2015)

Severe Bilateral Lower Extremity Pyoderma Gangrenosum
por: Laun, Jake, et al.
Publicado: (2016)

Rapid resolution of pyoderma gangrenosum with brodalumab therapy
por: Tee, Michael W., et al.
Publicado: (2020)

Penile Pyoderma Gangrenosum in Pediatric Ulcerative Colitis
por: Thomas, Michael J., et al.
Publicado: (2023)

Pyoderma Gangrenosum after Breast Mammoplasty Surgery: A Case Report
por: Fong, Chun Wa, et al.
Publicado: (2021)

Perforator propeller flap for coverage of Achilles region defects caused by pyoderma gangrenosum
por: Fong, Chun Wa, et al.
Publicado: (2022)

Conjugative transfer of ICESde3396 between three β-hemolytic streptococcal species
por: Smyth, Danielle J, et al.
Publicado: (2014)

Isavuconazonium for the treatment of Purpureocillium lilacinum infection in a patient with pyoderma gangrenosum
por: Accetta, Julia, et al.
Publicado: (2020)

M protein typing of Thai group A streptococcal isolates by PCR-Restriction fragment length polymorphism analysis
por: Yoonim, Nonglak, et al.
Publicado: (2005)

Evaluation of regression methods when immunological measurements are constrained by detection limits
por: Uh, Hae-Won, et al.
Publicado: (2008)

Evaluation of safety and immunogenicity of a group A streptococcus vaccine candidate (MJ8VAX) in a randomized clinical trial
por: Sekuloski, Silvana, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_709m6b5q7j9qs9euhbojf6upvi